Literature DB >> 1626454

Kawasaki disease with Reye syndrome: report of one case.

J H Lee1, H Y Hung, F Y Huang.   

Abstract

A seven-month-old girl was admitted to the Pediatrics Department of Mackay Memorial Hospital with the following symptoms and signs: (1) high fever for more than five days; (2) injection of bilateral conjunctiva; (3) bright red lips with strawberry tongue; (4) edematous change of palms and soles, followed by digit desquamation; (5) an ill-defined, erythematous plaque on the scar of the BCG. Kawasaki disease was diagnosed, and high dose aspirin (100 mg/kg/day) and intravenous gamma-globulin (IVIG) (400 mg/kg/day) were given for four days. The patient was afebrile on the second day after IVIG infusion, and was discharged six days after admission. A small single daily dose of aspirin (10 mg/kg/day) was given after the afebrile days. Unfortunately, vomiting and consciousness disturbance were noted one day after discharge. Laboratory data showed elevated aspartate aminotransferase (AST), alanine aminotransferase (ALT) and ammonia. Hypoglycemia and prolonged PT and PTT were also noted. Reye syndrome was suspected, and the patient was admitted to the intensive care unit for further management. A liver biopsy gave findings consistent with Reye syndrome. In spite of intensive treatment, the infant expired on the second day after admission. In a review of the literature, no correlation between these two syndromes was found. This rare case is presented to warn that Reye syndrome may follow Kawasaki disease when aspirin has been prescribed at a high dose.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1626454

Source DB:  PubMed          Journal:  Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi        ISSN: 0001-6578


  14 in total

Review 1.  Update on the treatment of Kawasaki disease in childhood.

Authors:  Robert P Sundel
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

Review 2.  Overview of pharmacological treatment of Kawasaki disease.

Authors:  Z Onouchi; T Kawasaki
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

3. 

Authors:  Teeranai Sakulchit; Susanne M Benseler; Ran D Goldman
Journal:  Can Fam Physician       Date:  2017-08       Impact factor: 3.275

Review 4.  Acetylsalicylic acid for children with Kawasaki disease.

Authors:  Teeranai Sakulchit; Susanne M Benseler; Ran D Goldman
Journal:  Can Fam Physician       Date:  2017-08       Impact factor: 3.275

5.  Hepatic dysfunction secondary to Kawasaki disease: characteristics, etiology and predictive role in coronary artery abnormalities.

Authors:  Goshgar Mammadov; Hui Hui Liu; Wei Xia Chen; Guo Zhen Fan; Rui Xue Li; Fei Fei Liu; Sama Samadli; Jing Jing Wang; Yang Fang Wu; Huang Huang Luo; Dong Dong Zhang; Wei Wei; Peng Hu
Journal:  Clin Exp Med       Date:  2019-11-16       Impact factor: 3.984

6.  Multisystem Inflammatory Syndrome in Children: Examining Emerging Data and Identifying Key Knowledge Gaps.

Authors:  Laura F Sartori; Fran Balamuth
Journal:  Pediatr Emerg Care       Date:  2022-02-01       Impact factor: 1.454

Review 7.  Integrative treatment of herbal medicine with western medicine on coronary artery lesions in children with Kawasaki disease.

Authors:  Jungyoon Choi; Seokjoo Chang; Eunjin Kim; Sang Yeon Min
Journal:  Medicine (Baltimore)       Date:  2022-02-18       Impact factor: 1.817

8.  Is high-dose aspirin necessary in the acute phase of kawasaki disease?

Authors:  Goni Lee; Seung Eun Lee; Young Mi Hong; Sejung Sohn
Journal:  Korean Circ J       Date:  2013-03-31       Impact factor: 3.243

9.  Kawasaki disease.

Authors:  Jane W Newburger; David R Fulton
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-04

10.  Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in Kawasaki disease.

Authors:  Karl Migally; Elizabeth A Braunlin; Lei Zhang; Bryce A Binstadt
Journal:  Pediatr Res       Date:  2018-05-02       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.